Comparison of A(H3N2) Neutralizing Antibody Responses Elicited by 2018–2019 Season Quadrivalent Influenza Vaccines Derived from Eggs, Cells, and Recombinant Hemagglutinin

Wei Wang(Shenzhen Bay Laboratory), Carol D. Weiss(Center for Biologics Evaluation and Research), Gregory Utz(Henry M. Jackson Foundation), Timothy Burgess(Uniformed Services University of the Health Sciences), Stephanie A Richard(Henry M. Jackson Foundation), Bruce McClenathan(Womack Army Medical Center), Katrin Mende, Tahaniyat Lalani(Henry M. Jackson Foundation), Christina Schofield(Madigan Army Medical Center), Ryan C. Maves(Naval Medical Center San Diego), David Hrncir(Wilford Hall Ambulatory Surgical Center), Rhonda E Colombo(Henry M. Jackson Foundation), Ana E Markelz(Uniformed Services University of the Health Sciences), Russell Vassell(Center for Biologics Evaluation and Research), Min Z. Levine(Centers for Disease Control and Prevention), Esmeralda Alvarado-Facundo(Center for Biologics Evaluation and Research), Srihari Seshadri(Defense Health Agency), Casey Geaney(Walter Reed National Military Medical Center), Anuradha Ganesan(Walter Reed National Military Medical Center), Christian Coles(Henry M. Jackson Foundation), Christina Spooner(Defense Health Agency), Tyler Warkentien(Walter Reed National Military Medical Center), Limone Collins(Defense Health Agency), Maryna C. Eichelberger(Center for Biologics Evaluation and Research)
Clinical Infectious Diseases
September 3, 2020
Cited by 27


Related Papers